GUIDANCE DOCUMENT
Hernia Mesh – Package Labeling Recommendations Draft Guidance for Industry and Food and Drug Administration Staff June 2025
Not for implementation. Contains non-binding recommendations.
This guidance is being distributed for comment purposes only.
Submit Comments by
Although you can comment on any guidance at any time (see 21 CFR 10.115(g)(5)), to ensure that the FDA considers your comment on a draft guidance before it begins work on the final version of the guidance, submit either online or written comments on the draft guidance before the close date.
If unable to submit comments online, please mail written comments to:
Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852
All written comments should be identified with this document's docket number: FDA-2025-D-1150
- Docket Number:
- FDA-2025-D-1150
- Issued by:
-
Guidance Issuing OfficeCenter for Devices and Radiological Health
This draft guidance document provides FDA’s recommendations on package labeling to support premarket submissions for hernia mesh devices. This guidance applies to certain surgical mesh devices that are intended for hernia repair. The standardized package labeling for hernia meshes recommended in this guidance may provide a more consistent format for disseminating certain clinically relevant information, making it easier for healthcare providers to find certain information needed to use the device safely and for the purposes for which it is intended. These labeling changes may also help mitigate the safety issues for hernia meshes due to suboptimal device selection.